Eikon Therapeutics, Inc. Common Stock (EIKN) SEC Filings: History & Chart

Eikon Therapeutics, Inc. Common Stock(EIKN)

Biotechnology · Millbrae, CA

$7.56+0.02 (+0.27%)

Delayed quote: Oct 6, 2026, 2:10 PM EDT

About Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.

Millbrae, CA

384 employees

eikontx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Roger Perlmutter

View full financials

Form	Filing Date	Accepted	Document
SC 13G/A	Oct 2, 2026	Oct 2, 2026	View filing
4	Sep 8, 2026	Sep 8, 2026	View filing
8-K	Aug 14, 2026	Aug 13, 2026	View filing
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
SC 13G/A	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 3, 2026	Aug 3, 2026	View filing
3	Jun 15, 2026	Jun 15, 2026	View filing
8-K	Jun 10, 2026	Jun 10, 2026	View filing
8-K	Jun 1, 2026	Jun 1, 2026	View filing
SC 13G	May 15, 2026	May 15, 2026	View filing
SC 13G	May 13, 2026	May 13, 2026	View filing
10-Q	May 11, 2026	May 11, 2026	View filing
8-K	May 11, 2026	May 11, 2026	View filing
SC 13G	May 6, 2026	May 6, 2026	View filing
SC 13G	Apr 29, 2026	Apr 29, 2026	View filing
8-K	Mar 30, 2026	Mar 30, 2026	View filing
10-K	Mar 30, 2026	Mar 30, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
4	Mar 4, 2026	Mar 4, 2026	View filing
SC 13G	Feb 18, 2026	Feb 18, 2026	View filing
SC 13D	Feb 12, 2026	Feb 12, 2026	View filing
SC 13G	Feb 11, 2026	Feb 11, 2026	View filing
4	Feb 10, 2026	Feb 10, 2026	View filing
4	Feb 9, 2026	Feb 9, 2026	View filing

SEC Filings

Recent Filings